Models of interactions between HIV and other pathogens.
暂无分享,去创建一个
[1] G. Friedland,et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.
[2] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[3] R. Winchester,et al. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization , 1980, The Journal of experimental medicine.
[4] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[5] J M Taylor,et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.
[6] T. Kirkwood,et al. A model of human immunodeficiency virus infection in T helper cell clones. , 1990, Journal of theoretical biology.
[7] J. Pocidalo,et al. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non‐progressors and progressors towards AIDS , 1990, Clinical and experimental immunology.
[8] R. Detels,et al. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.
[9] R. Levy,et al. Intracerebral-mass lesions in the acquired immunodeficiency syndrome (AIDS) , 1983, The New England journal of medicine.
[10] R. Prescott,et al. HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII , 1985, The Lancet.
[11] J. Revillard,et al. Elevation of serum β2-microglobulin levels during infectious mononucleosis , 1982 .
[12] R. Fernandez-Botran,et al. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells , 1988, The Journal of experimental medicine.
[13] F. Ognibene,et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. , 1987, The American review of respiratory disease.
[14] D. Cantrell,et al. Transient expression of interleukin 2 receptors. Consequences for T cell growth , 1983, The Journal of experimental medicine.
[15] M A Nowak,et al. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. , 1990, AIDS.
[16] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[17] A. Fauci,et al. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.
[18] A. Cann,et al. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. , 1988, Science.
[19] R. Detels,et al. Serum beta2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T‐cell fall and prognosis , 1990, AIDS.
[20] R. Cheynier,et al. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.